Showing 41 - 60 of 756 results
Our People
Our people, the custodians of Australia’s nuclear and accelerator expertise, are amongst our nation’s most talented researchers, scientists, engineers and nuclear experts. Everyday we work to respond to the growing nuclear science and technology needs of Australia and the world.
Nuclear Waste Solutions
Combining scientific expertise with more than $1.3 billion in unique operational assets to provide optimal radioactive waste solutions.
Total Fluorine Analysis
ANSTO offers accelerator-based particle-induced gamma-ray emission techniques to determine total fluorine concentration in a range of solid materials and rapidly screen for the presence of PFAS (perfluoroalkyl and polyfluoroalkyl substances).
ANSTO'S National Science Week Hackathon 2024
Nuclear medicine facilities
To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.
ANSTO Nuclear Medicine Project
An investment that will secure the long term sustainability of nuclear medicine supply in Australia.
Homepage
Work with us
ANSTO drives Australian innovation through partnerships designed to respond to the needs of industry. Get in touch to discuss business opportunities today.
Top innovation stories from 2022
2022 has been a big year for ANSTO with contributions to the advanced manufacturing, space, food, energy industries, and more. As we set our sights on 2023, we thought we’d take the opportunity to share some of our key innovation achievements from this year.
Careers at ANSTO
ANSTO seeks candidates who are passionate about making a contribution to Australian society through supporting nuclear science and technology.
Research supports potential local supply chain for component in COVID PCR test
University of Melbourne researchers have investigated a method to produce magnetic nanoparticles in Australia for use in COVID-19 PCR tests.
User Access
The User Office is the first point of contact for all new and returning facility users accessing ANSTO’s wide range of world-class research infrastructure. These users may be internal ANSTO researchers, external merit researchers, commercial clients, scientific collaborators and partners.
Medical Research Future Fund Grant targeting glioma with precision radiotherapy and biochemical dose amplification
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.
ANSTO recognises the contribution of staff for outstanding work, innovation, and excellence
ANSTO announces the recipients of the 2022 organisational awards
ANSTO's innovative approach to treating cancer gets funding
An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.
Safeguarding the future of Australia's nuclear medicine
The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.